Scienture Holdings (SCNX) Company Overview

Profile

Full Name:

Scienture Holdings, Inc.

Sector:

Healthcare

Country:

United States

IPO:

February 6, 2014

Indexes:

Not included

Description:

Scienture Holdings is a biotechnology company focused on developing innovative therapies and solutions for various medical conditions, aiming to improve patient outcomes through advanced scientific research and technology.

Key Details

Price

$2.66

Annual Revenue

$8.27 M(-19.30% YoY)

Annual EPS

-$23.35(-279.67% YoY)

Annual ROE

-4031.44%

Beta

1.94

Events Calendar

Earnings

Next earnings date:

Jun 26, 2025

Recent quarterly earnings:

Nov 6, 2024

Recent annual earnings:

Mar 29, 2021
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Jul 19, 2024
Splits

Next split:

N/A

Recent split:

Jun 22, 2023

Analyst ratings

Recent major analysts updates

No data about analysts updates

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Dividend per share

Dividend yield

Other

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Scienture Holdings?
  • Does Scienture Holdings pay dividends?
  • What sector is Scienture Holdings in?
  • What industry is Scienture Holdings in?
  • What country is Scienture Holdings based in?
  • When did Scienture Holdings go public?
  • Is Scienture Holdings in the S&P 500?
  • Is Scienture Holdings in the NASDAQ 100?
  • Is Scienture Holdings in the Dow Jones?
  • When was Scienture Holdings's last earnings report?
  • When does Scienture Holdings report earnings?
  • Should I buy Scienture Holdings stock now?

What is the ticker symbol for Scienture Holdings?

The ticker symbol for Scienture Holdings is NASDAQ:SCNX

Does Scienture Holdings pay dividends?

Yes, Scienture Holdings pays dividends. The last payment was $1.50, with an ex-dividend date on July 19, 2024

What sector is Scienture Holdings in?

Scienture Holdings is in the Healthcare sector

What industry is Scienture Holdings in?

Scienture Holdings is in the Pharmaceutical Retailers industry

What country is Scienture Holdings based in?

Scienture Holdings is headquartered in United States

When did Scienture Holdings go public?

Scienture Holdings's initial public offering (IPO) was on February 6, 2014

Is Scienture Holdings in the S&P 500?

No, Scienture Holdings is not included in the S&P 500 index

Is Scienture Holdings in the NASDAQ 100?

No, Scienture Holdings is not included in the NASDAQ 100 index

Is Scienture Holdings in the Dow Jones?

No, Scienture Holdings is not included in the Dow Jones index

When was Scienture Holdings's last earnings report?

Scienture Holdings's most recent earnings report was on Nov 6, 2024

When does Scienture Holdings report earnings?

The next expected earnings date for Scienture Holdings is Jun 26, 2025

Should I buy Scienture Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions